Manufacturing

Bioreactor Functions as Perfusion Mimic

Drug Quality and Security Act gives FDA authority over compounding pharmacies.

The international “Fight the Fakes” campaign will raise awareness about the dangers of counterfeit medicines.

In this sponsored podcast, Adam Stuart, Senior Design Engineer at 3M Drug Delivery Systems, discusses the role of dose counters for metered dose inhalers and the technical challenges companies can face when adding this feature to their inhaler products.

European Medicines Agency announces the launch of the Accelerated development of vaccine benefit-risk collaboration in Europe (ADVANCE) project.

GlaxoSmithKline plans to invest nearly $41 million to expand its operations at its facility in Montrose, the United Kingdom.

Merck KGaA plans to build a new biomanufacturing facility in Nantong, China.

The bacterial meningitis outbreak at Princeton University in recent weeks has raised questions about why there is no vaccine in the United States to prevent this deadly disease, when such a therapy is approved in Europe and Australia.

John J. Castellani, President and CEO of the Pharmaceutical Research and Manufacturers of America of the PhRMA Research & Hope awards and creating an ecosystem for promoting new vaccine development

Featured products from Pharmaceutical Technology's monthly newsletter, Equipment & Processing Report

An operational-excellence initiative increased collaboration between operations and quality personnel to address human-error-caused deviations.

New facility designs enable flexible, multiproduct production.

The Drug Quality and Security Act creates national standards for serialization of drug products to protect against counterfeiting.

Covance Inc. and Pathoquest have announced a collaboration to provide next-generation sequencing (NGS) based biosafety assessments to detect and identify viral contaminants within biologic compounds.

Ei Lilly announces investments in insulin manufacturing capacity for its sites in Indianapolis, Puerto Rico, France, and China.

Intertek is now offering comprehensive services for the development of orally inhaled and intranasal drug products (OINDPs) for both small molecules and biologics.

Screening methods and predictive models address tenacious tablet-sticking problems.

The systems are designed for the manufacture of oncology products and to research new biotech products.

Changes in the working procedures and disposable fluid flow paths resulted in a measurable decrease in product waste in a low-volume, high-value fill-finish line.

Schott’s glass vials are specially manufactured to control and reduce delamination potential.

Progress in delivery science, manufacturing technologies, and commercialization are playing critical roles in advancing the development of complex parenteral drug formulations for new drug substances having a variety of formulation challenges

AstraZeneca will build a new facility in the United Kingdom to produce Zoladex, an injectable prostrate cancer treatment.

Grifols expands and diversifies portfolio with acquisition of diagnostic business.

Breakthrough Therapies Raise Manufacturing Issues

ISPE's survey is industry's first large-scale effort to collect data on patient experiences with clinical trial materials.